Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer
This is a crisis scenario that defines a CEO's legacy. The decision matrix is clear: Patient safety and regulatory compliance must supersede short-term financial protection. Hiding this information constitutes securities fraud and potential criminal negligence (precedents include Vioxx/Merck and Purdue Pharma).Read the full answer